Search Results - "Cobb, O.E."

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease by Murphy, G.P., Tjoa, B.A., Simmons, S.J., Jarisch, J., Bowes, V.A., Ragde, H., Rogers, M., Elgamal, A., Kenny, G.M., Cobb, O.E., Ireton, R.C., Troychak, M.J., Salgaller, M.L., Boynton, A.L.

“…BACKGROUND A phase II trial was conducted to assess the efficacy of infusions of dendritic cells (DC) and two HLA‐A2‐specific PSMA peptides (PSM‐P1 and ‐P2)…”
Get full text

Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides by Tjoa, B.A., Simmons, S.J., Bowes, V.A., Ragde, H., Rogers, M., Elgamal, A., Kenny, G.M., Cobb, O.E., Ireton, R.C., Troychak, M.J., Salgaller, M.L., Boynton, A.L., Murphy, G.P.

“…BACKGROUND A phase I trial involving patients with advanced prostate cancer was conducted to assess the safe administration of dendritic cells (DC) and…”
Get full text

Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides by Tjoa, B.A., Erickson, S.J., Bowes, V.A., Ragde, H., Kenny, G.M., Cobb, O.E., Ireton, R.C., Troychak, M.J., Boynton, A.L., Murphy, G.P.

“…BACKGROUND We recently conducted a phase I clinical trial administering autologous dendritic cells pulsed with prostate‐specific membrane antigen (PSMA)…”
Get full text